RT Journal Article
SR Electronic
T1 Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001146
DO 10.1136/jitc-2020-001146
VO 8
IS 2
A1 Awada, Gil
A1 Ben Salama, Laila
A1 De Cremer, Jennifer
A1 Schwarze, Julia Katharina
A1 Fischbuch, Lydia
A1 Seynaeve, Laura
A1 Du Four, Stephanie
A1 Vanbinst, Anne-Marie
A1 Michotte, Alex
A1 Everaert, Hendrik
A1 Rogiers, Anne
A1 Theuns, Peter
A1 Duerinck, Johnny
A1 Neyns, Bart
YR 2020
UL http://jitc.bmj.com/content/8/2/e001146.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.